Mskcc.org

A mini-symposium in honor of the 100-year anniversary of her birth. November 23, 2020 from 12 PM to 3 PM.

New research focuses on clonal hematopoiesis, an age-related blood condition that increases the risk of blood cancer.

Dr. Thompson and MSK are being recognized with this prestigious award for leadership during the ongoing COVID-19 pandemic.

Targeting the cancer environment, rather than the cancer itself, could be a new avenue for immunotherapy.

Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.

Learn more about GSK’s PhD program and meet our team.

Though questions remain about how best to use genetic testing for cancer, the trend is toward more inclusive criteria.

A celebration over Zoom allowed MSK bone marrow transplant survivors to reminisce with medical staff and each other.

Computational biologist Thomas Norman, PhD, of Memorial Sloan Kettering’s (MSK) Sloan Kettering Institute (SKI) has been named one of 53 recipients of the prestigious 2020 National Institutes of Health (NIH) Director’s New Innovator Award. As part...

Recently developed targeted drugs used to treat lung cancer are only partially effective. Scientists now know why.

Learn about a new study led by MSK that suggests that children with cancer are no more likely than other kids to be infected with COVID-19 or to have severe symptoms when infected.

See what it's like to train at Memorial Sloan Kettering, a world-renowned academic medical center dedicated to patient care, research, and education.

MSK Infectious disease specialist Tobias Hohl answers questions cancer patients may have about tests for COVID-19 antibodies.

An antibody test developed at MSK could shed light on the immune response to the COVID-19 virus.

Collaboration leads to a new digital pathology tool that allows some doctors to diagnose patient tumors from home.